Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells.

Nitric oxide (NO) participates in the regulation of vascular tone and smooth muscle cell proliferation, but little is known of its effect on total protein and matrix synthesis in smooth muscle. We studied the effects of the NO-generating compounds S-nitroso-N-acetylpenicillamine (SNAP, 0.4 to 1.2 mmol/L) and sodium nitroprusside (SNP, 0.1 to 0.5 mmol/L) on total protein (using [3H]leucine) and collagen (using [3H]proline) synthesis in cultured rabbit aortic smooth muscle cells. Both agents caused dose-dependent inhibition of the relative rate of protein (maximum reduction of 87% [SNAP] and 80% [SNP]) and collagen synthesis, as measured by trichloroacetic acid-precipitated label. The magnitudes of percent inhibition of total protein and collagen synthesis were approximately equal. Inhibition of protein synthesis by SNAP and SNP was prevented by hemoglobin (10 mumol/L), suggesting that the protein synthesis inhibition was due to NO release. Inhibition of protein synthesis was reversible after removal of SNAP and SNP and was not caused by damage to the cells. These results suggest that NO may function as a modulator of vascular smooth muscle cell protein synthesis and production of extracellular matrix components.

[1]  L. Ignarro,et al.  Biological Actions and Properties of Endothelium-Derived Nitric Oxide Formed and Released From Artery and Vein , 1989, Circulation research.

[2]  E. Culotta,et al.  NO news is good news. , 1992, Science.

[3]  L. Ignarro,et al.  Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. , 1981, The Journal of pharmacology and experimental therapeutics.

[4]  R. Cohen,et al.  Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle , 1994, Nature.

[5]  U. Garg,et al.  Nitric oxide-generating vasodilators inhibit mitogenesis and proliferation of BALB/C 3T3 fibroblasts by a cyclic GMP-independent mechanism. , 1990, Biochemical and biophysical research communications.

[6]  P. Vanhoutte,et al.  Flow-induced release of endothelium-derived relaxing factor. , 1986, The American journal of physiology.

[7]  A. Newby,et al.  Inhibition of vascular smooth muscle cell proliferation by endothelium-dependent vasodilators. , 1992, Herz.

[8]  Y. Nunokawa,et al.  Interferon-gamma inhibits proliferation of rat vascular smooth muscle cells by nitric oxide generation. , 1992, Biochemical and biophysical research communications.

[9]  Hans Michael Piper,et al.  Cell Culture Techniques in Heart and Vessel Research , 1990, Springer Berlin Heidelberg.

[10]  W. Edwards,et al.  Primary pulmonary hypertension: a histopathologic study of 80 cases. , 1985, Mayo Clinic proceedings.

[11]  M. Reidy,et al.  Mechanisms of stenosis after arterial injury. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[12]  A. Hassid,et al.  Mechanisms of nitrosothiol-induced antimitogenesis in aortic smooth muscle cells. , 1993, European journal of pharmacology.

[13]  T. Kulik,et al.  Effect of stretch on growth and collagen synthesis in cultured rat and lamb pulmonary arterial smooth muscle cells , 1993, Journal of cellular physiology.

[14]  F. Murad,et al.  Guanylate cyclase: activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin. , 1978, Advances in cyclic nucleotide research.

[15]  F. Murad,et al.  Biochemical Mechanisms Underlying Vascular Smooth Muscle Relaxation: The Guanylate Cyclase‐Cyclic GMP System , 1988, Journal of cardiovascular pharmacology.

[16]  H. Schröder,et al.  Evidence for a correlation between nitric oxide formation by cleavage of organic nitrates and activation of guanylate cyclase. , 1985, Journal of molecular and cellular cardiology.

[17]  B. Brüne,et al.  Nitric oxide: a signal for ADP-ribosylation of proteins. , 1994, Life sciences.

[18]  A. Hassid,et al.  Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. , 1989, The Journal of clinical investigation.

[19]  M A Schork,et al.  Type I collagen gene expression in human atherosclerosis. Localization to specific plaque regions. , 1993, The American journal of pathology.

[20]  L. Ignarro,et al.  Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. , 1979, Journal of cyclic nucleotide research.

[21]  R. Diegelmann,et al.  Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteins. , 1971, Biochemistry.

[22]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[23]  R. Ross The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[24]  A. Newby,et al.  Serum-induced proliferation of rabbit aortic smooth muscle cells from the contractile state is inhibited by 8-Br-cAMP but not 8-Br-cGMP. , 1990, Atherosclerosis.

[25]  G. Angelini,et al.  The future of saphenous vein as a coronary artery bypass conduit. , 1989, European heart journal.

[26]  R. Furchgott,et al.  Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. , 1985, The Journal of pharmacology and experimental therapeutics.

[27]  T. Billiar,et al.  Nitric oxide and nitric oxide‐generating compounds inhibit hepatocyte protein synthesis , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  M. Rekhter,et al.  Endothelialized myointimal thickening in the rat aorta as a result of extensive freeze injury. , 1993, Atherosclerosis.